FDA approves first non-invasive DNA test for colorectal cancer

Big news in the colorectal cancer prevention and screening community yesterday! In a never-before-seen move, the Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly proposed Cologuard as a new option for colorectal cancer screening. What is Cologuard? Cologuard, produced by Exact Sciences, is a non-invasive (not requiring insertion of instruments…  Read More

Fight Colorectal Cancer Thanks Bipartisan Leaders for Requesting a Fix from the White House on a Medicare Error Impacting Colorectal Cancer Screening

FOR IMMEDIATE RELEASE Key congressional committee members send letter to White House pointing out contradictions in Medicare law, asking for the removal of a “counterproductive, inconsistent and unfair” policy involving cost-sharing for colonoscopy.  Alexandria, Va. – May 30, 2014 – Fight Colorectal Cancer is pleased to hear that President Obama received a letter today signed by…  Read More

Why Do Drugs Cost So Much?

by Chris Adams A response to A Tale of Two Drugs, an article by Barry Werth published in the MIT Technology Review Oct. 2013 Drug prices. Why are they so high? In a recent article for the MIT Technology Review, Barry Werth considers the pricing of two recently developed and very expensive drugs. The first drug…  Read More

Seniors and the Screening Loophole

“But doctor, I thought screening for colorectal cancer was covered by Medicare!?” Our seniors are facing policy loophole that lands them with an unexpected bill. In a recent report, Colonoscopy Screening After the Affordable Care Act: Cost Barriers Persist for Medicare Beneficiaries on the colonoscopy copay issue by AARP, there continues to be a debate about what portion of…  Read More

ACA Mandates Insurance Coverage for Clinical Trials

By January 1, all insurers will be required to cover routine care for patients enrolled in clinical trials. (Typically any experimental care is provided at no cost to the patient.) “This should be seen as a step forward for the U.S. oncology community,” wrote Dr. Y-Ning Wong in the ASCO Daily News from the American Society of…  Read More

Too Many Colonoscopies in Over-75s?

A study published in the March 11 JAMA-Internal Medicine suggests that 23 percent of over-75-year-olds have colonoscopies that may be “potentially inappropriate” according to national guidelines which include an upper age limit, as well as how often negative colonoscopies should be repeated. In a retrospective population study, University of Texas researchers looked at billings for 100…  Read More